Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)

CUSIP: 22978P106

Q2 2022 13F Holders as of 30 Jun 2022

Holder snapshot 7 signals
Share change
-3,653,279
Put/Call ratio
39%
SEC-reported price per share
$2.49
Number of holders
68
Value change
-$10,988,434
Number of buys
39
Open additional details 1 more signal available
Number of sells
52
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
43,411,663

Security key

22978P106

Report period

Q2 2022

Institutions

68

Top holders

10

Ownership snapshot

Top reported holders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F Lead comparable stake: 5.5% Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. leads the comparable SEC ownership view at 5.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock Finance, Inc. 5.5%
Nantahala Capital Management, LLC 5.2%
VANGUARD GROUP INC 3.8%
Prosight Management, LP 3.5%
Slate Path Capital LP 3.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
5.5%
$11,622,000
2,381,267 shares
31 Mar 2022
Nantahala Capital Management, LLC
13F
Company
13F
5.2%
$10,952,000
2,244,359 shares
31 Mar 2022
VANGUARD GROUP INC
13F
Company
13F
3.8%
$8,070,000
1,653,737 shares
31 Mar 2022
Prosight Management, LP
13F
Company
13F
3.5%
$7,370,000
1,510,282 shares
31 Mar 2022
Slate Path Capital LP
13F
Company
13F
3.4%
$7,240,000
1,483,619 shares
31 Mar 2022
SANDERS MORRIS HARRIS LLC
13F
Company
13F
2%
$4,261,000
873,021 shares
31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
68
Shares
14,083,808
Rows available
68
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
97
Q2 2022 holders
68
Holder diff
-29
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .